POLARIS TRIAL
The POLARiS trial will investigate the clinical and cost benefit of two treatments for patients with major LARS who have previously undergone standard non-surgical treatment without improvement.
Buyer
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Value
£1,833,551
Published
11 May 2023
Closes
11 May 2023
Procurement details
Source
Sell2Wales
Region
United Kingdom
Procurement method
Limited
Category
Services
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
79314000
Feasibility study
Lots
Lot 1 POLARIS TRIAL
£1,833,551
14,000 cases of rectal cancer are diagnosed in the UK per year. The treatment for advanced rectal cancer is often radiotherapy+/-chemotherapy treatment followed by surgery. This provides good outcomes, with the cancer returning in less than 10% of people. However, the surgery can cause significant long-lasting problems, including problems with bowel, sexual...
Delivery: Cardiff and Vale of Glamorgan
Documents
Unlock document linkPOLARIS TRIAL
Not provided
The POLARiS trial will investigate the clinical and cost benefit of two treatments for patients with major LARS who have previously undergone standard non-surgical treatment without improvement.
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.